Elizabeth Delmaestro

1 week ago | pharmaceuticalonline.com | Elizabeth Delmaestro |Raul P. Lima |Andrew Milner

Enabling Subcutaneous Delivery For Improved Patient ComplianceThe ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens. Discover how Nanoform Biologics’ innovative approach to high-dose subcutaneous delivery of biologics addresses the challenges of traditional SC delivery methods.